JPRN-jRCT1052230161
Active, not recruiting
Phase 3
Validation of Pathophysiology in Heart Failure Exacervation using echo Vector Flow Mapping
Kawaji Testuma0 sites400 target enrollmentJanuary 9, 2024
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- heart failure
- Sponsor
- Kawaji Testuma
- Enrollment
- 400
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients who receive transthoracic echocardiography in our hospital
- •patints who can be followed for at least 1 year
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of heart failure pathophysiology targeting cardiac cyclic GMPPatients with heart failureJPRN-UMIN000049990Tohoku University Hospital50
Completed
Not Applicable
Implementation and Evaluation of Heart Failure Patients Discharge PlaHeart Failure.Heart failure, unspecifiedI50.9IRCT20190205042636N1niversity of social welfare and rehabilitation sciences26
Completed
Not Applicable
eural Cardiac Therapy for Heart Failure Studycardiac remodelingHeart failure10019280NL-OMON46859Boston Scientific20
Completed
Not Applicable
Evaluation of severity of heart failure using non-invasive monitoring system with conactless sheet sensorchronic heart failureJPRN-UMIN000028034Department of Cardiovascular Surgery, Osaka University100
Completed
Not Applicable
Chronic Heart failure Analysis and Registry in the Tohoku district 2;Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.Chronic heart failure (Stage C/D)JPRN-UMIN000018007Department of Cardiovascular Medicine and Department of Evidence-Based Cardiovascular Medicine, Tohoku University Graduate School of Medicine and Tohoku heart failure association2,688